NeuoroNesic Pain Relieving Cream

Manufacturer
Blaine Labs Inc.
Effective date
2026-09-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-09-08 02:01:42

Label at a glance#

ProductNeuroNesic Pain Relieving Cream
Active ingredientCAPSAICIN
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

DRUG FACTS

Active Ingredients

Capsaicin ............ 0.1%

OTC - PURPOSE SECTION

Purpose  ............... Topical Analgesic

INDICATIONS & USAGE SECTION

USES ■ For temporary relief from minor aches and pains of sore
muscles and joints associated with arthritis pain, simple backache,
strains and sprains ■ Provides warming pain relief 

WARNINGS SECTION

Warnings- for external use only

Do not use: ■ on wounds or damaged skin with a heating pad

■ if allergic to capsicum or chili peppers

When using this produc: ■  test on a small area of skin before
first use to check for skin sensitivity ■ avoid contact with eyes or
mucous membranes ■ do not bandage tightly ■ do not expose area
to direct heat or direct sunlight ■ a slight burning sensation may
occur upon application and generally disappears within several days              

Stop use and ask a physician if: ■ condition worsens

■ redness is present ■ symptoms persist for more than 7 days or
clear up and occur again within a few days ■ excessive skin
irritation develops

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or
contact a poison control center (1-800-222-2222) immediately

DOSAGE & ADMINISTRATION SECTION

Directions

■  Adults and children 18 years of age and older:Apply to affected
area no more than 3 to 4 times daily. Wash hands with soap and
water after each use.
■  Children under 18 years of age:do not use, consult a physician.

OTHER SAFETY INFORMATION

Other Information

Store in a cool, dry place at 15º-30ºC (59º-86ºF).

INACTIVE INGREDIENT SECTION

Inactive Ingredients 

Alkyl (C12-15) Benzoate, Caprylyl Glycol, Carica Papaya (Papaya)
Fruit Extract, Carthamus Tinctorius (Safflower) Seed Oil, Cetyl Alcohol,
Dimethicone, Disodium EDTA, Emulsifying Wax, Ethylhexylglycerin,
Glycerin, Glyceryl Stearate, Hexylene Glycol, Hydrogenated
Polydecene, Hydroxyethyl Cellulose, PEG-100 Stearate,
Phenoxyethanol, Propylene Glycol, Purified Water, Sodium Lactate,
Sodium Polyacrylate, Trideceth-6, Xanthan Gum

NeuroNesic Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

----------------------------------------------

BLAINE LABS                                        DISPENSED EXCLUSIVELY BY PHYSICIANS

NeuroNesic™
PAIN-RELIEVING CREAM

INGREDIENTS INCLUDE
PROPRIETARY BLEND OF
PAPAYA EXTRACT AND
SAFFLOWER SEED OIL

3.0 0Z (85.0 g)

MANUFACTURED BY: Blaine Labs, Inc.
11037 Lockport Place, Santa Fe Springs, CA 90670
MADE IN THE U.S.A


QUESTIONS OR COMMENTS?
(800) 307-8818 M-F 7:30AM - 4:00PM (PST)

100-01 Tube100-01 Tube

RES

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63347-99963347-999-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NeuroNesic Pain Relieving CreamCAPSAICINBlaine Labs Inc.7107c13d-bf59-4c0a-84fe-725a9fca26912026-09-04WarningsExact identifier
ndc (package): 63347-999-01
ndc (product): 63347-999
ndc11 (package): 63347099901
spl id: 5aab3dd9-6e8e-f16c-e063-6294a90a9644
spl set id: 7107c13d-bf59-4c0a-84fe-725a9fca2691

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.